These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1573 related items for PubMed ID: 7667166

  • 1. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS, Kashyap ML.
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [Abstract] [Full Text] [Related]

  • 3. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 4. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.
    McKenney JM.
    Pharmacotherapy; 1993 Jul; 13(4):340-52. PubMed ID: 8361860
    [Abstract] [Full Text] [Related]

  • 5. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 Jul; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 6. [Disorders of lipid metabolism in insulin resistance].
    Müller-Wieland D, Krone W.
    Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
    [Abstract] [Full Text] [Related]

  • 7. Statins and diabetes.
    Carmena R, Betteridge DJ.
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [Abstract] [Full Text] [Related]

  • 8. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [Abstract] [Full Text] [Related]

  • 9. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 10. Comparison of effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in diabetic patients with mixed dyslipidemia (from the Diabetes and Combined Lipid Therapy Regimen study).
    May HT, Anderson JL, Pearson RR, Jensen JR, Horne BD, Lavasani F, Yannicelli HD, Muhlestein JB.
    Am J Cardiol; 2008 Feb 15; 101(4):486-9. PubMed ID: 18312763
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology of hyperlipidemia in diabetes mellitus.
    Abbate SL, Brunzell JD.
    J Cardiovasc Pharmacol; 1990 Feb 15; 16 Suppl 9():S1-7. PubMed ID: 1710739
    [Abstract] [Full Text] [Related]

  • 12. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 15; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 13. Advances in drug treatment of dyslipidemia: focus on atorvastatin.
    Davignon J.
    Can J Cardiol; 1998 May 15; 14 Suppl B():28B-38B. PubMed ID: 9627539
    [Abstract] [Full Text] [Related]

  • 14. Lipids and lipoproteins in normal dogs and in dogs with secondary hyperlipoproteinemia.
    Rogers WA, Donovan EF, Kociba GJ.
    J Am Vet Med Assoc; 1975 Jun 01; 166(11):1092-1100. PubMed ID: 166057
    [Abstract] [Full Text] [Related]

  • 15. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Jun 01; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 16. Effects of various lipid-lowering treatments in diabetics.
    Steiner G.
    J Cardiovasc Pharmacol; 1990 Jun 01; 16 Suppl 9():S35-9. PubMed ID: 1710744
    [Abstract] [Full Text] [Related]

  • 17. Management of hyperlipidemia in diabetes mellitus.
    Dunn FL.
    Endocrinol Metab Clin North Am; 1992 Jun 01; 21(2):395-414. PubMed ID: 1612072
    [Abstract] [Full Text] [Related]

  • 18. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Jun 01; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 19. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J.
    Schweiz Med Wochenschr; 1994 Nov 05; 124(44):1933-7. PubMed ID: 7973520
    [Abstract] [Full Text] [Related]

  • 20. Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.
    Siraj ES, Seyoum B, Saenz C, Abdulkadir J.
    Metabolism; 2006 Jun 05; 55(6):706-10. PubMed ID: 16713427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.